| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―19 |
Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks |
Jiajun Xu, Raghad Abdulsalam Khaleel, Haider Kamil Zaidan, Ahmed Faisal Mutee, Khaled Fahmi Fawy, Anita Gehlot, Alaa Hashim Abbas, José Luis Arias Gonzáles, Ali H Amin, Maribel Carmen Ruiz-Balvin, Shima Imannezhad, Abolfazl Bahrami, Reza Akhavan-Sigari |
| 2 |
[GO] |
2023―Jul―24 |
COVID-19 of differing severity: from bulk to single-cell expression data analysis |
Linlin Tian, Min He, Huafeng Fan, Hongying Zhang, Xiaoxiao Dong, Mengkai Qiao, Chenyu Tang, Yan Yu, Tong Chen, Nan Zhou |
| 3 |
[GO] |
2022―Jul―19 |
Application of emetine in SARS-CoV-2 treatment: regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications |
Mehdi Valipour, Hamid Irannejad, Saeed Emami |
| 4 |
[GO] |
2021―Sep―29 |
Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19 |
Mehdi Valipour, Afshin Zarghi, Mohammad Ali Ebrahimzadeh, Hamid Irannejad |
| 5 |
[GO] |
2020―Dec―31 |
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? |
Farshad Abedi, Ramin Rezaee, A. Wallace Hayes, Somayyeh Nasiripour, Gholamreza Karimi |
| 6 |
[GO] |
2020―Dec―11 |
Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication |
Mehrdad Ghashghaeinia, Peter Dreischer, Thomas Wieder, Martin Köberle |
| 7 |
[GO] |
2020―Dec―11 |
Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2. |
Neil D. Theise, Anthony R. Arment, Dimple Chakravarty, John M. H. Gregg, Ira M. Jacobson, Kie Hoon Jung, Sujit S. Nair, Ashutosh K. Tewari, Archie W. Thurston, John Van Drie, Jonna B. Westover |
|
